We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
On Holding
ONON
$11.7B
| $67.7M | 0.13% |
1,301,100
-94,063
| -7% | -$4.79M |
2023 Q3
7 quarters
|
|
202
Grab
GRAB
$13.1B
| $67.6M | 0.13% |
13,444,746
+1,095,855
| +9% | +$5.11M |
2023 Q3
7 quarters
|
|
203
American Express
AXP
$208B
| $67.2M | 0.13% |
210,564
-21,351
| -9% | -$6.01M |
2013 Q2
48 quarters
|
|
204
Silicon Laboratories
SLAB
$7.41B
| $66.8M | 0.13% |
453,027
-97,665
| -18% | -$11.6M |
2013 Q2
48 quarters
|
|
205
EOG Resources
EOG
$77.7B
| $66.2M | 0.12% |
553,817
-22,706
| -4% | -$2.59M |
2013 Q2
48 quarters
|
|
206
Coupang
CPNG
$28.4B
| $66.2M | 0.12% |
2,210,621
+1,310,337
| +146% | +$33.6M |
2022 Q4
10 quarters
|
|
207
Sherwin-Williams
SHW
$77.5B
| $66M | 0.12% |
192,206
-8,800
| -4% | -$3.05M |
2013 Q2
48 quarters
|
|
208
M&T Bank
MTB
$31.4B
| $65.5M | 0.12% |
337,762
-55,462
| -14% | -$9.79M |
2013 Q2
48 quarters
|
|
209
Birkenstock
BIRK
$5.56B
| $65.5M | 0.12% |
1,331,927
+379,759
| +40% | +$19.5M |
2023 Q4
6 quarters
|
|
210
BWX Technologies
BWXT
$13.2B
| $65M | 0.12% |
450,907
+372,800
| +477% | +$43.6M |
2022 Q1
13 quarters
|
|
211
nVent Electric
NVT
$27.1B
| $64.9M | 0.12% |
885,918
-237,783
| -21% | -$14.6M |
2018 Q2
28 quarters
|
|
212
Clean Harbors
CLH
$16.7B
| $64.6M | 0.12% |
279,341
-122,131
| -30% | -$26.7M |
2013 Q2
48 quarters
|
|
213
Target
TGT
$69.8B
| $64.3M | 0.12% |
651,689
-4,758
| -0.7% | -$457K |
2013 Q2
48 quarters
|
|
214
Ryman Hospitality Properties
RHP
$8.3B
| $64.2M | 0.12% |
650,577
-369
| -0.1% | -$34.5K |
2014 Q3
43 quarters
|
|
215
Ares Management
ARES
$26.7B
| $64.1M | 0.12% |
370,000
-105,000
| -22% | -$16.6M |
2018 Q1
29 quarters
|
|
216
Blackrock
BLK
$168B
| $63M | 0.12% |
60,035
-5,824
| -9% | -$5.51M |
2013 Q2
48 quarters
|
|
217
Rezolute
RZLT
$471M
| $62.6M | 0.12% |
14,034,712
+2,755,385
| +24% | +$10.2M |
2020 Q4
18 quarters
|
|
218
Zoetis
ZTS
$30.9B
| $62.3M | 0.12% |
399,172
-68,430
| -15% | -$10.9M |
2013 Q2
48 quarters
|
|
219
Datadog
DDOG
$105B
| $62.2M | 0.12% |
462,771
-580,854
| -56% | -$64.3M |
2020 Q2
20 quarters
|
|
220
Northern Trust
NTRS
$30.8B
| $62.1M | 0.12% |
489,989
+10,243
| +2% | +$1.05M |
2013 Q2
48 quarters
|
|
221
Stryker
SYK
$106B
| $62M | 0.12% |
156,675
+2,242
| +1% | +$839K |
2013 Q2
48 quarters
|
|
222
Arcturus Therapeutics
ARCT
$391M
| $61.1M | 0.12% |
4,694,060
| – | – |
2020 Q2
20 quarters
|
|
223
CAVA Group
CAVA
$6.27B
| $61.1M | 0.11% |
724,855
-499,584
| -41% | -$42.6M |
2023 Q2
8 quarters
|
|
224
Berkshire Hathaway Class B
BRK.B
$1.1T
| $60.6M | 0.11% |
124,767
+315
| +0.3% | +$160K |
2013 Q2
48 quarters
|
|
225
BILL Holdings
BILL
$3.82B
| $60.3M | 0.11% |
1,303,473
+639,502
| +96% | +$28.3M |
2023 Q4
6 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.